SCHEMBL20094342

SCHEMBL20094342

FC(F)(F)c1ccc2nc(C3CC3)nn2c1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XPO1 O14980 2/20 0.35
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
ADRB2 P07550 1/20 0.31
RBP4 P02753 1/20 0.31
MALT1 Q9UDY8 4/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
KCNH2 Q12809 1/20 0.31
PDE4D Q08499 1/20 0.31
TRPV1 Q8NER1 1/20 0.30
GRIA2 P42262 1/20 0.30
GRIN1 Q05586 1/20 0.30
GRIN2A Q12879 1/20 0.30
LRRK2 Q5S007 1/20 0.30
PDE8B O95263 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20088499 0.77 PDE10A (0.38) KDM4EPDE4DGRIA2GRIN1GRIN2A
SCHEMBL20088505 0.77 PDE4D (0.33) PDE4D
SCHEMBL20088518 0.77 PDE4D (0.31) PDE4D
SCHEMBL20094260 0.76 ALDH1A1 (0.37) XPO1ALDH1A1KDM4EHPGDADRB2
SCHEMBL20094275 0.75 PDE10A (0.36) XPO1ALDH1A1KDM4EADRB2
SCHEMBL20094349 0.74 HRH4 (0.35) XPO1PDE4DPDE8B
SCHEMBL20106739 0.74 PDE4D (0.32) PDE4D
SCHEMBL20094345 0.73 TSHR (0.37) XPO1PDE4DLRRK2
SCHEMBL20094344 0.73 ALDH1A1 (0.34) XPO1ALDH1A1KDM4EADRB2
SCHEMBL20094357 0.73 DHODH (0.40) XPO1ALDH1A1KDM4EADRB2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109963851-B Fused bicyclic pyridine compounds and their use as AMPA receptor modulators 詹森药业有限公司 2021-11-30 CN disclosed
EP-3532477-B1 FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-08-26 EP disclosed
EP-3532477-B1 FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-08-26 EP disclosed
US-10087185-B2 Fused bicylic pyridine compounds and their use as AMPA receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2018-10-02 US disclosed
WO-2018080917-A1 FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-03 WO disclosed
US-20180111933-A1 FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-04-26 US disclosed
US-20180111933-A1 FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10087185-B2 Fused bicylic pyridine compounds and their use as AMPA receptor modulators GRIN1, GRIN3A, GRM1 XPO1 3363/4885ALDH1A1 1440/4885KDM4E 2891/4885
US-20180111933-A1 FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS GRIN1, GRIN3A, GRM1 XPO1 3363/4885ALDH1A1 1440/4885KDM4E 2891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.